The FDA and ECT.
Publication
, Journal Article
McDonald, WM; Weiner, RD; Fochtmann, LJ; McCall, WV
Published in: J ECT
June 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J ECT
DOI
EISSN
1533-4112
Publication Date
June 2016
Volume
32
Issue
2
Start / End Page
75 / 77
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Psychiatry
- Product Labeling
- Mental Disorders
- Humans
- Electroconvulsive Therapy
- 5203 Clinical and health psychology
- 3209 Neurosciences
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
McDonald, W. M., Weiner, R. D., Fochtmann, L. J., & McCall, W. V. (2016). The FDA and ECT. J ECT, 32(2), 75–77. https://doi.org/10.1097/YCT.0000000000000326
McDonald, William M., Richard D. Weiner, Laura J. Fochtmann, and W Vaughn McCall. “The FDA and ECT.” J ECT 32, no. 2 (June 2016): 75–77. https://doi.org/10.1097/YCT.0000000000000326.
McDonald WM, Weiner RD, Fochtmann LJ, McCall WV. The FDA and ECT. J ECT. 2016 Jun;32(2):75–7.
McDonald, William M., et al. “The FDA and ECT.” J ECT, vol. 32, no. 2, June 2016, pp. 75–77. Pubmed, doi:10.1097/YCT.0000000000000326.
McDonald WM, Weiner RD, Fochtmann LJ, McCall WV. The FDA and ECT. J ECT. 2016 Jun;32(2):75–77.
Published In
J ECT
DOI
EISSN
1533-4112
Publication Date
June 2016
Volume
32
Issue
2
Start / End Page
75 / 77
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Psychiatry
- Product Labeling
- Mental Disorders
- Humans
- Electroconvulsive Therapy
- 5203 Clinical and health psychology
- 3209 Neurosciences
- 3202 Clinical sciences